SANDLER LAURA LEE (Chief Operating Officer) sold 2.1% of their position (5K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $459.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/1/2026ACC: 0000907654-26-000088
Officer· Chief Operating Officer
Since Mar 2026
-5K
Net shares
Net seller
$459.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5K
Price / share
$7.80
Trade value
$39K
% of position
2.1%
9/1/2026
236.38K→241.38K
Common Stock
Direct
Shares
−1K
Price / share
$91.05
Trade value
$91.05K
% of position
0.4%
9/1/2026
241.38K→240.38K
Common Stock
Direct
Shares
−4K
Price / share
$92.01
Trade value
$368.05K
% of position
1.7%
9/1/2026
240.38K→236.38K
Total
Net shares
+0.00
Net value
-$420.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +5K | $7.80 | $39K | 2.1% | 236.38K | 241.38K |
| Common Stock Direct | 9/1/2026 | S · Sale | −1K | $91.05 | $91.05K | 0.4% | 241.38K | 240.38K |
| Common Stock Direct | 9/1/2026 | S · Sale | −4K | $92.01 | $368.05K | 1.7% | 240.38K | 236.38K |
| Total | +0.00 | -$420.10K | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
7.80
Held after
75K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock5K shares | 9/1/2026 | M · Option Exercise | −5K | 7.80 | — | 75K |